NVD is a breakthrough cancer detection technology. It conducts an optical analysis of a standard biopsy slide to detect molecular changes in nuclear structure not detectable by pathology. Molecular changes manifest first, allowing earlier & more accurate cancer detection. In addition, NVD predicts which precancerous lesion will progress to cancer. This breakthrough capability will save lives and reduce costs.